ADORA2B and neoplasm: This cell-type-specific crosstalk—confined to CD8+ T cells in GC TME—creates a synergistic immunosuppressive loop, where Adora2b and PD-1 mutually reinforce each other’s signaling to impair anti-tumor cytotoxicity.